News
Académie suisse des sciences techniques SATW
Switzerland as a centre of innovation: International settlements as a driver of growth
Switzerland's innovative strength is recognised worldwide. However, the global competition for AI talent and technologies requires more than just good framework conditions - it needs targeted international networking.
Académie suisse des sciences techniques SATW
News
From foresight to first patients: HAYA Therapeutics enters the clinic
The Lausanne-based company HAYA Therapeutics, featured in the Technology Outlook showcase “The cryptic messages of our genome”, has reached two significant milestones in quick succession: the first cohort of participants has been dosed in a Phase 1 clinical trial of its lead candidate HTX-001, and the company has been named a “Disruptive Pioneer” in the 2026 Global Pharmaceutical Innovation and Invention Index published by IDEA Pharma. These developments underscore the relevance of the technology identified by SATW’s foresight activities.Académie suisse des sciences techniques SATW
News
Regulating AI - easier said than done. A day between paragraphs, satellites and start-ups
Technopark Zurich normally belongs to start-ups. But on 27 March 2026, lawyers, administrative experts, researchers and digital activists took over: The Law & Tech Lab at the University of St. Gallen hosted the third AI conference. The key question: How should artificial intelligence be regulated in Switzerland - and when is the right time to do so?Académie Suisse des Sciences Médicales ASSM
News
Prise de position: surveillance digitale dans les soins
Des systèmes de surveillance digitale sont de plus en plus souvent utilisés dans les hôpitaux et dans les soins de longue durée. Ils promettent un gain de sécurité et d’efficacité, ainsi qu’une aide à la prise en charge. En même temps, ils soulèvent des questions médico-éthiques et juridiques fondamentales. La Commission Centrale d’Éthique (CCE) de l’ASSM prend position à ce sujet.